• 
  Guillaume Patient, Corentin Bedart, N. A. Khan, Nicolas Renault, Amaury Farce. Distinct binding hotspots for natural and synthetic agonists of FFA4 from in silico approaches.. Molecular Informatics, 2024, Mol Inform, Online ahead of print. ⟨10.1002/minf.202400046⟩. ⟨hal-04711589⟩
• 
  Thierry Lecomte, David Tougeron, Romain Chautard, Diane Bressand, Frédéric Bibeau, et al.. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR). Digestive and Liver Disease, 2024, 56 (5), pp.756-769. ⟨10.1016/j.dld.2024.01.208⟩. ⟨hal-04647877⟩
• 
  Pierre-Grégoire Guinot, Olivier Desebbe, Guillaume Besch, Philippe Guerci, Philippe Gaudard, et al.. Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial). American Heart Journal, 2024, 272, pp.86-95. ⟨10.1016/j.ahj.2024.03.008⟩. ⟨hal-04699433⟩
• 
  Victor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, Stanislas Pol, Dulce Alfaiate, et al.. Treatment With Bulevirtide in HIV Infected patients With chronic Hepatitis Delta. ANRS HD EP01 BULEDELTA & Compassionate Cohort. JHEP Reports Innovation in Hepatology, 2024, pp.101057. ⟨10.1016/j.jhepr.2024.101057⟩. ⟨hal-04596035⟩
• 
  Selma El Messaoudi, Segolene Brichler, Claire Fougerou-Leurent, Emmanuel Gordien, Athenaïs Gerber, et al.. Effect of Peg-IFN on the viral kinetics of HDV infected patients treated with bulevirtide. JHEP Reports Innovation in Hepatology, 2024, pp.101070. ⟨10.1016/j.jhepr.2024.101070⟩. ⟨hal-04526834⟩

798

1 163